Odyssey toward an understanding of acquired postinflammatory lentiginosis.
Curr Opin Pediatr
; 33(6): 704-708, 2021 12 01.
Article
em En
| MEDLINE
| ID: mdl-34734917
ABSTRACT
PURPOSE OF REVIEW Acquired postinflammatory lentiginosis is a phenomenon that has been previously termed 'induction of lentiginosis in assorted dermatoses' or the ILIAD phenomenon. RECENT FINDINGS:
Although some cases have been described as arising exclusively in those who applied topical calcineurin inhibitors (TCIs), other patients have presented with similar findings in other nonatopic disorders (contact dermatitis, psoriasis, lichen planus, focal dermal hypoplasia), and without antecedent use of TCIs.SUMMARY:
Inflammatory skin disorders can produce localized areas of cutaneous lentiginosis, particularly as the inflammation retreats in response to treatment. This post-inflammatory lentiginosis or ILIAD phenomenon may be potentiated by use of topical and systemic anti-inflammatory medications, including TCIs, topical corticosteroids, methotrexate, and systemic biologic agents. Although this phenomenon has not been associated with melanocytic neoplasia, ongoing periodic monitoring for dysplastic changes is reasonable.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fármacos Dermatológicos
/
Lentigo
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article